Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
about
The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosisEffect of connective tissue growth factor (CCN2/CTGF) on proliferation and differentiation of mouse periodontal ligament-derived cells.Swimming exercise prevents fibrogenesis in chronic kidney disease by inhibiting the myofibroblast transdifferentiationIncreased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.Transforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors.Fibroblast heterogeneity in physiological conditions and fibrotic disease.Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.Adoptive transfer murine model of granulomatous experimental autoimmune thyroiditis.Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-betaScleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis.Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1).Transforming growth factor-beta in disease: the dark side of tissue repair.Dog mastocytoma cells produce transforming growth factor beta 1Clinical comments and a pathophysiological discussion of scleroderma.Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta.Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.A brief overview of the pathogenesis of scleroderma (systemic sclerosis)Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.Collagenous colitis and eosinophilic gastritis in a 4-year old girl: a case report and review of the literature.Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.Exploring anti-TGF-β therapies in cancer and fibrosis.Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter.Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma.Recent advances in animal models of systemic sclerosis.Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast.Adhesion molecules in scleroderma: collagen binding integrins.Regulation of connective tissue synthesis in systemic sclerosis.The immunologic and genetic basis of avian scleroderma, an inherited fibrotic disease of line 200 chickens.Role of transforming growth factor beta (TGF beta) in systemic autoimmunity.TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2.Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF.Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair.Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.Binding of upstream stimulatory factor to an E-box in the 3'-flanking region stimulates alpha1(I) collagen gene transcription.Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts.
P2860
Q24799804-49116632-1DC7-40BE-83F9-FC38237784EEQ24812930-B364E9A9-06CC-4A00-8D36-4632FC3D40F2Q28480806-05454390-E52F-476B-827C-BC975AA47591Q33566537-E53193D5-AA6C-4CE3-B686-A0B5B6539786Q33851819-2F207CC3-62D8-452D-B051-CDB8BDF31D22Q33893414-9014DBF0-4E01-4D96-86A3-F371F2B6094AQ34005595-B2D310EF-3AD3-40F1-9781-E7B8DC7A5B30Q34005608-19AF7444-94A2-4FB8-9B8A-72850FB0FA6BQ34112877-BB82816B-B234-44DA-8F8A-658ED118906BQ34140802-04488FDD-B326-46A8-A962-9EDF47FB6A5BQ34747455-ECAC9B26-8CB6-402C-B6D4-D19BF7D23919Q35602823-A9C32974-2BA0-40EA-B605-331FBEB0F0DEQ35603155-A1C5B336-DB94-4977-9385-EFCF50DED57DQ35603298-F0132466-1D7A-4792-99C2-2F023F99DEA1Q35654907-1E615DDF-FA5A-4EBB-B159-454A200A0B00Q35833446-56FB427E-0DAF-4E2C-BE9C-45BA38AA79E0Q35843492-91DB3079-2C51-47A5-A4E8-6813A4DA5A06Q35927432-184B4747-9857-4C0E-B21E-2F16BFBB06C5Q36231258-3EF26859-7F47-4688-A4B3-00EC996F9E3AQ36918944-15531E88-2C7C-4FFD-BC6D-F230ED45CC3DQ37768336-3ABCC27B-7A92-496D-ADED-28340360FB6FQ37896073-9CB7B86B-2F27-4E8E-AA6D-BD1AA6C0506BQ38327280-62C769B6-5288-4EB5-8529-7154B3F102A6Q38334009-6B0D978E-B4F4-417D-BE41-56357121B500Q38360649-C41CECCE-4699-4DDF-B66D-68A5935DAC6AQ38701983-FCA37FB2-67F9-4B71-AAE3-D6219818C7C4Q40306122-7DC7CDB0-CD09-4273-9A7C-D4B7D149F50DQ40403505-27C0D5CF-44A7-4EF4-894B-CF56FFCF52BFQ40468537-EC01F1C1-859B-4E06-900C-F51711E161EEQ40635218-175B975A-03CB-4B4E-A5AF-A876AD7AC5A9Q40794752-E641F1CE-0AFD-4D00-B3E5-9935E4D5A0A4Q41072991-E798103D-A338-4794-8A21-737257D847FEQ41252594-BC14BC0D-B672-486A-94BE-A1CAF174E27AQ41368727-C1977310-2948-43EA-B6C7-6D5CC9A5BA70Q41619893-A4DA8058-E572-4419-B43F-951C656E14C6Q42098930-1C888C1E-723B-472B-832F-3B12D99737B5Q42494727-BA8483C1-B418-4715-AAE4-2CBBDCC9269BQ42804627-DFB3EFB9-E6B9-4A9E-B95B-3716C5ECF48DQ42981818-6042F468-FCC2-4A4D-B9FF-794F3668176BQ43795671-666F8997-6F3B-42A7-8456-C97971FE1499
P2860
Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Co-localization of transforming growth factor beta 2 with alpha 1
@nl
Co-localization of transformin ...... ients with systemic sclerosis.
@ast
Co-localization of transformin ...... ients with systemic sclerosis.
@en
type
label
Co-localization of transforming growth factor beta 2 with alpha 1
@nl
Co-localization of transformin ...... ients with systemic sclerosis.
@ast
Co-localization of transformin ...... ients with systemic sclerosis.
@en
prefLabel
Co-localization of transforming growth factor beta 2 with alpha 1
@nl
Co-localization of transformin ...... ients with systemic sclerosis.
@ast
Co-localization of transformin ...... ients with systemic sclerosis.
@en
P2093
P2860
P356
P1476
Co-localization of transformin ...... ients with systemic sclerosis.
@en
P2093
Lankat-Buttgereit B
P2860
P304
P356
10.1172/JCI114793
P407
P577
1990-09-01T00:00:00Z